Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Other Accumulated Expenses: 2022-2024

Historic Other Accumulated Expenses for Immuneering (IMRX) over the last 3 years, with Sep 2024 value amounting to $59,657.

  • Immuneering's Other Accumulated Expenses fell 25.89% to $59,657 in Q3 2024 from the same period last year, while for Sep 2024 it was $59,657, marking a year-over-year decrease of 25.89%. This contributed to the annual value of $259,770 for FY2023, which is 1212.23% up from last year.
  • Immuneering's Other Accumulated Expenses amounted to $59,657 in Q3 2024, which was down 33.89% from $90,242 recorded in Q2 2024.
  • In the past 5 years, Immuneering's Other Accumulated Expenses registered a high of $259,770 during Q4 2023, and its lowest value of $19,796 during Q4 2022.
  • Its 3-year average for Other Accumulated Expenses is $65,932, with a median of $47,213 in 2022.
  • The largest annual percentage gain for Immuneering's Other Accumulated Expenses in the last 5 years was 1,212.23% (2023), contrasted with its biggest fall of 44.23% (2023).
  • Immuneering's Other Accumulated Expenses (Quarterly) stood at $19,796 in 2022, then skyrocketed by 1,212.23% to $259,770 in 2023, then fell by 25.89% to $59,657 in 2024.
  • Its last three reported values are $59,657 in Q3 2024, $90,242 for Q2 2024, and $23,634 during Q1 2024.